Comparison

TML-6 European Partner

Item no. TMO-T37148-10mg
Manufacturer TargetMol
CASRN 1462868-88-7
Amount 10 mg
Quantity options 100 mg 100 mg 10 mg 25 mg 25 mg 50 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,98
Formula C30H37NO7
Smiles CCN(CC)C(=O)CC(C)(C(=O)\C=C\c1ccc(OC)c(OC)c1)C(=O)\C=C\c1ccc(OC)c(OC)c1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
Others|||Nrf2|||mTOR|||Beta Amyloid|||NF-κB
Shipping Temperature
Cool pack
Storage Conditions
-20°C
Molecular Weight
523, 62
Description
TML-6, an oral curcumin derivative, demonstrates inhibitory effects on the synthesis of β-amyloid precursor protein and β-amyloid (Aβ). Additionally, TML-6 exhibits upregulation of Apo E, suppression of NF-κB and mTOR, and enhancement of the anti-oxidative Nrf2 gene activity. Considering its diverse pharmacological profile, TML-6 holds promise as a valuable research tool for investigating Alzheimer's disease (AD)[1].
Pathways
NF-κB|||Immunology/Inflammation|||PI3K/Akt/mTOR signaling|||Neuroscience|||Others
Bioactivity
TML-6, an orally active curcumin derivative, inhibits the synthesis of the β-amyloid precursor protein and β-amyloid (Aβ). TML-6 can upregulate Apo E, suppress NF-κB and mTOR, and increase the activity of the anti-oxidative Nrf2 gene. TML-6 has the potential for Alzheimer’s disease (AD) research[1].

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close